Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A Comparison of Globally Applied Prognostic Risk Groups and the Prevalence of Metastatic Disease on Prostate-specific Membrane Antigen Positron Emission Tomography in Patients with Newly Diagnosed Prostate Cancer.
Eur Urol Oncol. 2024 Apr 30:S2588-9311(24)00097-X. doi: 10.1016/j.euo.2024.04.005. Online ahead of print.
Eur Urol Oncol. 2024.
PMID: 38693019
Free article.
The Probability of Metastases Within Different Prostate-specific Antigen Ranges Using Prostate-specific Membrane Antigen Positron Emission Tomography in Patients with Newly Diagnosed Prostate Cancer.
Luining WI, Hagens MJ, Meijer D, Ringia JB, de Weijer T, Bektas HO, Ettema RH, Knol RJJ, Roeleveld TA, Srbljin S, Weltings S, Koppes JCC, van Moorselaar RJA, van Leeuwen PJ, Oprea-Lager DE, Vis AN.
Luining WI, et al.
Eur Urol Open Sci. 2023 Dec 22;59:55-62. doi: 10.1016/j.euros.2023.12.001. eCollection 2024 Jan.
Eur Urol Open Sci. 2023.
PMID: 38298765
Free PMC article.
Item in Clipboard
Optimization and validation of 18F-DCFPyL PET radiomics-based machine learning models in intermediate- to high-risk primary prostate cancer.
Luining WI, Oprea-Lager DE, Vis AN, van Moorselaar RJA, Knol RJJ, Wondergem M, Boellaard R, Cysouw MCF.
Luining WI, et al.
PLoS One. 2023 Nov 9;18(11):e0293672. doi: 10.1371/journal.pone.0293672. eCollection 2023.
PLoS One. 2023.
PMID: 37943772
Free PMC article.
Item in Clipboard
The Diagnostic Value of PSMA PET/CT in Men with Newly Diagnosed Unfavorable Intermediate-Risk Prostate Cancer.
Hagens MJ, Luining WI, Jager A, Donswijk ML, Cheung Z, Wondergem M, Oprea-Lager DE, Vis AN, van Leeuwen PJ, van der Poel HG.
Hagens MJ, et al. Among authors: luining wi.
J Nucl Med. 2023 Aug;64(8):1238-1243. doi: 10.2967/jnumed.122.265205. Epub 2023 Jun 29.
J Nucl Med. 2023.
PMID: 37385673
Item in Clipboard
A prospective, multicenter head-to-head comparative study in patients with primary high-risk prostate cancer investigating the bone lesion detection of conventional imaging and 18F-PSMA-PET/CT.
Bodar YJL, Luining WI, Keizer B, Meijer D, Vellekoop A, Schaaf M, Hendrikse NH, Van Moorselaar RJA, Oprea-Lager DE, Vis AN.
Bodar YJL, et al. Among authors: luining wi.
Urol Oncol. 2023 Apr;41(4):205.e17-205.e24. doi: 10.1016/j.urolonc.2022.12.006. Epub 2022 Dec 30.
Urol Oncol. 2023.
PMID: 36588019
Free article.
Item in Clipboard
Targeting PSMA Revolutionizes the Role of Nuclear Medicine in Diagnosis and Treatment of Prostate Cancer.
Luining WI, Cysouw MCF, Meijer D, Hendrikse NH, Boellaard R, Vis AN, Oprea-Lager DE.
Luining WI, et al.
Cancers (Basel). 2022 Feb 24;14(5):1169. doi: 10.3390/cancers14051169.
Cancers (Basel). 2022.
PMID: 35267481
Free PMC article.
Review.
Item in Clipboard
Nuclear Imaging for Bone Metastases in Prostate Cancer: The Emergence of Modern Techniques Using Novel Radiotracers.
Luining WI, Meijer D, Dahele MR, Vis AN, Oprea-Lager DE.
Luining WI, et al.
Diagnostics (Basel). 2021 Jan 13;11(1):117. doi: 10.3390/diagnostics11010117.
Diagnostics (Basel). 2021.
PMID: 33450817
Free PMC article.
Review.
Item in Clipboard
Cite
Cite